Bell Potter analyst Martyn Jacobs maintained a Buy rating on Biome Australia Ltd (BIO – Research Report) today and set a price target of ...

Headquartered in Minneapolis, Minnesota, Bio-Techne Corporation (TECH) is a leading provider of life sciences solutions ...

Arcus Biosciences shares were down 14%, to $11.33, after the company priced a $150 million stock offering. Shares of the biopharmaceutical company hit their 52-week low of $10.65 earlier in the ...

We recently compiled a list of the 10 Micro and Small-Cap Firms Drive Year-to-Date Gains. In this article, we are going to take a look at where Rapid Micro Biosystems, Inc.

Bio-Rad Laboratories, Inc. BIO recently entered into a binding agreement to purchase all equity interests in Stilla Technologies ("Stilla"). Stilla’s next-generation digital PCR solutions complement ...

Solid Biosciences (SLDB) stock surges after strong Phase 1/2 data for its Duchenne therapy SGT-003. Read more here.

Zura Bio Limited (NASDAQ:ZURA – Get Free Report) has earned an average recommendation of “Buy” from the seven brokerages that ...

INmune Bio (NASDAQ:INMB – Get Free Report) had its price target hoisted by investment analysts at Maxim Group from $22.00 to $30.00 in a research note issued to investors on Thursday,Benzinga reports.

RBC Capital lowered the firm’s price target on Bio-Rad (BIO) to $447 from $477 and keeps an Outperform rating on the shares. The company ...

The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $8.38, a high ...